GGrantIndex
← Search

Integrated Genomics Shared Resource

$293,916P30FY2020CANIH

Case Western Reserve University, Cleveland OH

Investigators

Linked publications, trials & patents

Trial NCT05340673Trial NCT05198830Trial NCT02590107Trial NCT02535325Trial NCT02451124Trial NCT02419846Trial NCT02417948Trial NCT02392377Trial NCT02388932Trial NCT02383433Trial NCT02375477Trial NCT02354326Trial NCT02345460Trial NCT02342730Trial NCT02337465Trial NCT02327390Trial NCT02319889Trial NCT02307474Trial NCT02287636Trial NCT02252393Trial NCT02181478Trial NCT02179762Trial NCT02163317Trial NCT02158767Trial NCT02153450Trial NCT02135562Trial NCT02131207Trial NCT02129582Trial NCT02129569Trial NCT02129517Trial NCT02129218Trial NCT02128373Trial NCT02108587Trial NCT02100423Trial NCT02084147Trial NCT02082405Trial NCT02081794Trial NCT02079155Trial NCT02073097Trial NCT02073045Trial NCT02071901Trial NCT02070458Trial NCT02070419Trial NCT02055586Trial NCT02037048Trial NCT01973062Trial NCT01959490Trial NCT01959477Trial NCT01954784Trial NCT01954732Trial NCT01951885Trial NCT01939028Trial NCT01928485Trial NCT01894061Trial NCT01408043Trial NCT00991991Trial NCT00970684Trial NCT00961220Trial NCT00956475Trial NCT00952939Trial NCT00949247Trial NCT00945061Trial NCT00941720Trial NCT00941070Trial NCT00939510Trial NCT00918892Trial NCT00918788Trial NCT00918658Trial NCT00918216Trial NCT00910039Trial NCT00909662Trial NCT00908739Trial NCT00908141Trial NCT00907699Trial NCT00905086Trial NCT00900133Trial NCT00899158Trial NCT00899132Trial NCT00898573Trial NCT00898274Trial NCT00897143Trial NCT00892385Trial NCT00873600Trial NCT00873002Trial NCT00866320Trial NCT00856115Trial NCT00853021Trial NCT00842452Trial NCT00809185Trial NCT00796978Trial NCT00795678Trial NCT00769951Trial NCT00769249Trial NCT00752323Trial NCT00740961Trial NCT00736216Trial NCT00735514Trial NCT00733252Trial NCT00732745Trial NCT00732173

Abstract

INTEGRATED GENOMICS SHARED RESOURCE PROJECT SUMMARY/ABSTRACT The Integrated Genomics Shared Resource (Genomics SR) is an essential asset to Case Comprehensive Cancer Center (Case CCC) members' research, illustrated by the breadth of scientific program involvement and reflected in the large number of investigators who use this SR. Last year alone, over 230 investigators, 36% of whom were Case CCC members, accounting for 65% of total usage, from all 7 of the Case CCC Programs used the SR. The mission of the Genomics SR is to enable robust use of high-throughput genomics technologies and data analysis for cancer research projects. This multi-site SR is jointly supported and managed by the Case CCC, the Case Western Reserve University (CWRU) School of Medicine (SOM), and Cleveland Clinic (CC) Lerner Research Institute (LRI). It provides access to a full spectrum of genomics technologies including multi- site Next Generation Sequencing (NGS) for DNA and RNA analyses. The Specific Aims of the Genomics SR are to: 1. Provide project-level genomics consultation services to assist investigators in experimental design, technology selection, assembling of key resources to execute projects, collect samples, assure overall project quality control, and identify best analytical approaches. 2. Provide access to a full range of genomic technologies, including: a) Sample preparation & sample quality assessment services: Nucleic Acid Isolation from difficult samples; Evaluation of nucleic acid quality for downstream analysis. b) Comprehensive genomics analyses: RNA-based services: RNA-seq, custom Illumina RNA panels, RNA expression analysis using Affymetrix microarray technology, real-time PCR; DNA-based services: Next- Generation Sequencing (whole genome, and -exome custom, amplicon sequencing, microbiome analysis, CRISPR validation, ChIP-Seq analysis); methylation analysis, Sanger sequencing and genotyping (TaqMan Assays, Microarrays). 3. Provide a range of genomics analysis support including access to and training on genomics analysis software; and execution of high-end analysis including development of genomics pipelines for specific projects and for investigators with limited analysis experience. Throughout the current funding cycle (2012-2016), the Genomics SR provided services to 479 registered users, 134 (28%) of whom are Case CCC members, representing all 7 of the Case CCC programs. Finally, the Genomics SR feels that rapid access to a focused, well-executed data analysis pipeline is critical to the success of investigators? genomic studies. To this end, the Genomics SR developed an Analytics Component, which ensures that each project has robust experiment design and data analysis plans before initiation.

View original record on NIH RePORTER →